Is DOC Underperforming the Real Estate Sector?

Healthpeak Properties, Inc. (DOC) is a prominent real estate investment trust that specializes in owning, operating, and developing top-tier healthcare-related properties across the United States. These properties include life sciences campuses, outpatient medical offices, and senior housing facilities. Headquartered in Denver, Colorado, Healthpeak Properties plays a vital role in supporting healthcare delivery and fostering innovation through its diverse real estate portfolio. With a market capitalization of approximately $11.9 billion, the company is classified as a large-cap stock.

The company’s strategic focus on disciplined execution and a targeted approach has been instrumental in realizing its long-term growth objectives consistently. Despite facing challenges, Healthpeak Properties remains resilient in achieving its vision for sustained growth and success in the real estate market.

In recent times, Healthpeak Properties’ stock has experienced fluctuations, currently down by 16.9% from its 52-week high of $20.52 reached in March 2025. However, over the past three months, the stock has gained 6.6%, outperforming the Real Estate Select Sector SPDR Fund’s marginal rise during the same period.

Although the stock has faced a decline of 7.7% over the past six months and 16.2% over the past 52 weeks, Healthpeak Properties continues to trade above the 50-day moving average since mid-February. However, it remains below the 200-day moving average, indicating some volatility in the market.

The challenging real estate landscape, rising interest rates, and transitions towards life sciences properties have impacted Healthpeak Properties’ stock performance over the past year. Factors such as increased borrowing costs, reduced investor interest in income-focused assets, and leasing risks associated with life sciences properties have contributed to the stock’s decline. Slower leasing activity and financial strains among biotech tenants have further dampened growth expectations for the company.

In comparison to its peer Omega Healthcare Investors, Inc., Healthpeak Properties has significantly lagged behind in terms of stock performance. While Omega Healthcare Investors has seen gains of 7.9% over the past six months and a surge of 19.1% over the past year, Healthpeak Properties continues to face challenges in the market.

Analysts covering the DOC stock have a consensus rating of “Moderate Buy,” with a mean price target of $19.47, indicating a potential upside of 14.2% from current price levels. It is essential to consider these insights while evaluating investment opportunities in Healthpeak Properties.

In conclusion, Healthpeak Properties remains a key player in the real estate market, with a strong focus on healthcare-related properties. Despite facing challenges, the company’s strategic approach and long-term vision position it for potential growth opportunities in the future. Investors should carefully assess market conditions and analyst recommendations before making investment decisions related to Healthpeak Properties’ stock.

Please note that all information and data in this article are for informational purposes only. For more details, the original article can be found on Barchart.com.